RxDoctor Payments Data

Laine Way

Family Medicine · Manning, SCNPI 1114487519

Payments from drug & device makers

$3,348in general payments, 2019–2025

Across 146 payments — averaging $22.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$570
  • Novo Nordisk$517
  • Amgen$400
  • Novartis$302
  • GSK$229
  • Lilly USA, LLC$222
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$3,348100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,348 in reported general payments places this provider in the 80th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin44$53,191
MounjaroTirzepatide34$34,741
EliquisApixaban20$28,632
OzempicSemaglutide20$21,047
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$16,883
JanuviaSitagliptin Phosphate15$16,279
FarxigaDapagliflozin Propanediol12$15,667
Synjardy XrEmpagliflozin/Metformin Hcl15$14,195
MyrbetriqMirabegron19$13,154
Tresiba Flextouch U-200Insulin Degludec12$8,362
Repatha SureclickEvolocumab12$5,692
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$4,472
Gabapentin119$2,277
Atorvastatin Calcium186$1,953
Novolog FlexpenInsulin Aspart13$1,707

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy Xr$133$67,38659 claims
Lilly USA, LLCMounjaro$222$34,74134 claims
PfizerEliquis$35$28,63220 claims
GSKTrelegy Ellipta, Anoro Ellipta$229$21,35438 claims
Novo NordiskOzempic$517$21,04720 claims
AstraZenecaFarxiga$570$15,66712 claims
Astellas Pharma US IncMyrbetriq$48$13,15419 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Manning

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →